Delivery Order SPE2DB20D3103-SPE2DB24FN7X0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,874.04, is for the delivery of Lotrel 10-20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through September 21, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,090.96 firm fixed-price delivery order is for the supply of Lotrel 10-20 mg capsules. The contract has an ultimate completion date of June 20, 2023 and was awarded on June 16, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,023.63 firm fixed-price delivery order is for the supply of 100 capsules of the medication Lotrel 5-10 mg. The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award, with ID SPE2DB24D2205|SPE2DB24FDZPV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $25,597.88 firm fixed-price delivery order is for the supply of 4,565,712,418 units of the drug Lotrel 10-20 mg capsules. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,132.72, is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- The Defense Logistics Agency (DLA) awarded a $10,580.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LOTREL 10-20 MG CAPSULE 100S. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a firm-fixed-price delivery order (SPE2DB22D1017|SPE2DB24FG3LG) from the Defense Logistics Agency (DLA) Troop Support Medical valued at $3,929.10. The contract is for the supply of LOTREL 10-20 MG CAPSULE 100S, a prescription medication, to support military treatment programs and facilities. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,129.07, is for the supply of LOTREL 5-20 MG CAPSULE 100S, a cardiovascular medication. The award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,556,732,085 units of the drug LOTREL 10-20 mg capsules, a medication used to treat high blood pressure. The contract has a ceiling value of $42,822.93 and a completion date of March 30, 2022. It is a firm-fixed-price contract, meaning the price will not adjust based on the...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $14,672.10 firm fixed price delivery order contract to provide 4561308215 LOTREL 10-20 MG CAPSULE 100S. The prime contractor will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania by June 21, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN7X0Delivery Order
This federal contract award is for the delivery of Lotrel 10-20 mg capsules to the Defense Logistics Agency (DLA). The $20,780.76 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 13, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be a task order issued against that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 5/10/24 |